197 related articles for article (PubMed ID: 37602717)
1. Inhibition of galectin-3 post-infarction impedes progressive fibrosis by regulating inflammatory profibrotic cascades.
Wang X; Gaur M; Mounzih K; Rodriguez HJ; Qiu H; Chen M; Yan L; Cooper BA; Narayan S; Derakhshandeh R; Rao P; Han DD; Nabavizadeh P; Springer ML; John CM
Cardiovasc Res; 2023 Nov; 119(15):2536-2549. PubMed ID: 37602717
[TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction.
Lax A; Sanchez-Mas J; Asensio-Lopez MC; Fernandez-Del Palacio MJ; Caballero L; Garrido IP; Pastor-Perez FJ; Januzzi JL; Pascual-Figal DA
JACC Heart Fail; 2015 Jan; 3(1):50-58. PubMed ID: 25458175
[TBL] [Abstract][Full Text] [Related]
3. IL (Interleukin)-10-STAT3-Galectin-3 Axis Is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction.
Shirakawa K; Endo J; Kataoka M; Katsumata Y; Yoshida N; Yamamoto T; Isobe S; Moriyama H; Goto S; Kitakata H; Hiraide T; Fukuda K; Sano M
Circulation; 2018 Oct; 138(18):2021-2035. PubMed ID: 29967195
[TBL] [Abstract][Full Text] [Related]
4. Genetic Deletion of Galectin-3 Alters the Temporal Evolution of Macrophage Infiltration and Healing Affecting the Cardiac Remodeling and Function after Myocardial Infarction in Mice.
Cassaglia P; Penas F; Betazza C; Fontana Estevez F; Miksztowicz V; Martínez Naya N; Llamosas MC; Noli Truant S; Wilensky L; Volberg V; Cevey ÁC; Touceda V; Cicale E; Berg G; Fernández M; Goren N; Morales C; González GE
Am J Pathol; 2020 Sep; 190(9):1789-1800. PubMed ID: 32473918
[TBL] [Abstract][Full Text] [Related]
5. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin.
Liu YH; D'Ambrosio M; Liao TD; Peng H; Rhaleb NE; Sharma U; André S; Gabius HJ; Carretero OA
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H404-12. PubMed ID: 19098114
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction.
Asensio-Lopez MDC; Lax A; Fernandez Del Palacio MJ; Sassi Y; Hajjar RJ; Pascual-Figal DA
Transl Res; 2018 Sep; 199():4-23. PubMed ID: 29753686
[TBL] [Abstract][Full Text] [Related]
7. CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) Axis in Cardiac Fibrosis and Inflammation.
Martínez-Martínez E; Brugnolaro C; Ibarrola J; Ravassa S; Buonafine M; López B; Fernández-Celis A; Querejeta R; Santamaria E; Fernández-Irigoyen J; Rábago G; Moreno MU; Jaisser F; Díez J; González A; López-Andrés N
Hypertension; 2019 Mar; 73(3):602-611. PubMed ID: 30612490
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 interferes with tissue repair and promotes cardiac dysfunction and comorbidities in a genetic heart failure model.
Vlachou F; Varela A; Stathopoulou K; Ntatsoulis K; Synolaki E; Pratsinis H; Kletsas D; Sideras P; Davos CH; Capetanaki Y; Psarras S
Cell Mol Life Sci; 2022 Apr; 79(5):250. PubMed ID: 35441327
[TBL] [Abstract][Full Text] [Related]
9. Circulating Galectin-3 Levels Are Increased in Patients with Ischemic Heart Disease, but Are Not Influenced by Acute Myocardial Infarction.
Singsaas EG; Manhenke CA; Dickstein K; Orn S
Cardiology; 2016; 134(4):398-405. PubMed ID: 27120522
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 deletion exacerbates cardiac interstitial fibrosis by promoting M2 macrophage activation in mice after myocardial infarction.
Shivshankar P; Halade GV; Calhoun C; Escobar GP; Mehr AJ; Jimenez F; Martinez C; Bhatnagar H; Mjaatvedt CH; Lindsey ML; Le Saux CJ
J Mol Cell Cardiol; 2014 Nov; 76():84-93. PubMed ID: 25128086
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Administration of Eicosapentaenoic Acid Improves Post-Myocardial Infarction Cardiac Remodeling in Mice by Regulating Macrophage Polarization.
Takamura M; Kurokawa K; Ootsuji H; Inoue O; Okada H; Nomura A; Kaneko S; Usui S
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28223437
[TBL] [Abstract][Full Text] [Related]
12. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
13. Possible mechanism by which renal sympathetic denervation improves left ventricular remodelling after myocardial infarction.
Zheng XX; Li XY; Lyu YN; He YY; Wan WG; Zhu HL; Jiang XJ
Exp Physiol; 2016 Feb; 101(2):260-71. PubMed ID: 26556551
[TBL] [Abstract][Full Text] [Related]
14. Macrophage overexpression of matrix metalloproteinase-9 in aged mice improves diastolic physiology and cardiac wound healing after myocardial infarction.
Meschiari CA; Jung M; Iyer RP; Yabluchanskiy A; Toba H; Garrett MR; Lindsey ML
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H224-H235. PubMed ID: 29030341
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin attenuates sympathetic hyperinnervation together with the augmentation of M2 macrophages in rats postmyocardial infarction.
Yang N; Cheng W; Hu H; Xue M; Li X; Wang Y; Xuan Y; Li X; Yin J; Shi Y; Yan S
Cardiovasc Ther; 2016 Aug; 34(4):234-44. PubMed ID: 27149420
[TBL] [Abstract][Full Text] [Related]
16. Protective role of 5-azacytidine on myocardial infarction is associated with modulation of macrophage phenotype and inhibition of fibrosis.
Kim YS; Kang WS; Kwon JS; Hong MH; Jeong HY; Jeong HC; Jeong MH; Ahn Y
J Cell Mol Med; 2014 Jun; 18(6):1018-27. PubMed ID: 24571348
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
Milliez P; Messaoudi S; Nehme J; Rodriguez C; Samuel JL; Delcayre C
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
[TBL] [Abstract][Full Text] [Related]
18. Phloretin ameliorates heart function after myocardial infarction via NLRP3/Caspase-1/IL-1β signaling.
Li B; Xu L; Liu J; Zhou M; Jiang X
Biomed Pharmacother; 2023 Sep; 165():115083. PubMed ID: 37413902
[TBL] [Abstract][Full Text] [Related]
19. Early and delayed tranilast treatment reduces pathological fibrosis following myocardial infarction.
See F; Watanabe M; Kompa AR; Wang BH; Boyle AJ; Kelly DJ; Gilbert RE; Krum H
Heart Lung Circ; 2013 Feb; 22(2):122-32. PubMed ID: 22986349
[TBL] [Abstract][Full Text] [Related]
20. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.
Yu L; Ruifrok WP; Meissner M; Bos EM; van Goor H; Sanjabi B; van der Harst P; Pitt B; Goldstein IJ; Koerts JA; van Veldhuisen DJ; Bank RA; van Gilst WH; Silljé HH; de Boer RA
Circ Heart Fail; 2013 Jan; 6(1):107-17. PubMed ID: 23230309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
